MDxHealth (R): SelectMDx improves prostate biopsy decision-making in urology practices

Go back to MDxHealth (R): SelectMDx improves prostate biopsy decision-making in urology practices
(NASDAQ: MDXH) Delayed: 0.46 --0 (-0%)
Previous Close $0.46    52 Week High
Open $0.46    52 Week Low
Day High $0.46    P/E N/A 
Day Low $0.46    EPS
Volume 45,037